版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
1、EquityResearch7June2018BarclaysCapitalInc.oneofitsaffiliatesdoesseekstodobusinesswithcompaniescoveredinitsresearchrepts.Asaresultinvestsshouldbeawarethatthefirmmayhaveaconflictofinterestthatcouldaffecttheobjectivityofthi
2、srept.Investsshouldconsiderthisreptasonlyasinglefactinmakingtheirinvestmentdecision.PLEASESEEANALYSTCERTIFICATION(S)IMPTANTDISCLOSURESBEGINNINGONPAGE20.U.S.LifeScienceTools&DiagnosticsJack’sToolKit–Vol.4Issue23:Takeaways
3、fromASMS2018Jack’sToolKit–WhatareyourtakeawaysfromASMS2018onmassspectrometryfyourcoverageTriviaQuestion:Withamarketcapof$7.73bnExactSciencesis53%ofthesizeofQuestDiagnostics.RecentNotes&Repts:1)Tools&Dx:BarclaysToolsIndus
4、trialTrackerMay2018:GlobalPMIsExpansionaryUSShowsImprovement2)Tools&Dx:LabsApril2018EmploymentTrendsReview3)HOLX:May2018MammographyMarketModelUpdate4)GHDX:TAILxShowsValuefIntermediateRiskPatientsFullyValuedinStock.Barcla
5、ysLifeScienceTools&Dx5)AgilentTechnologies:AnalystDayTakeaways:ConsistentStrategytoOutGrowPeersBarclaysGeographicEndMarketTracker:AgilentFY3Q18PMITrackerof54.9(down0.4qq)MettlerToledo2Q18PMITrackerof55.7down1.3qq)PerkinE
6、lmer2Q18PMITrackerof55.3(down1.4qq)ThermoFisher2Q18PMITrackerof55.8(down1.2qq)Waters2Q18PMITrackerof55.1(down1.2qq).BarclaysFXTracker(662018):Eurostrengthens0.9%wwUKPoundstrengthens1.0%wwChineseYuanstrengthens0.5%wwJapan
7、eseYenweakens1.2%wwSwissFrancstrengthens0.3%ww.HotTopicsftheWeek:1)GenomicHealthreleasedtheresultsoftheTAILxstudyshowingthevalueofOncotypeDxinpredictingbenefitfromchemotherapyfbreastcancerpatients.2)BrukernamedGeraldHerm
8、annasthecompany’spermanentCFO.3)AgilenthostedananalystdayonWednesdayhighlightingaconsistentstrategylongtermtargetsalsodisclosedthatthecompanycompleted$200millionofrepurchasesinMaygivenrecentstockunderperfmance.Ourcoverag
9、euniversefinishedtheweekup3.5%sincelastThursday(toolsup4.5%diagnosticsup3.8%labs&CROsup2.2%).IncomparisontheS&P500wasup2.4%ftheweektheRussell2000wasup2.0%theNASDAQCompositewasup3.0%.StatoftheWeek:Agilent’scurrentexposure
10、toNGSwkflowswassizedat$250mm.DearClient:WeappreciateyourconsiderationintheInstitutionalInvestAllAmericaEquityResearchTeamSurvey.Toviewthisyear’srosterpleaseclickhere.INDUSTRYUPDATEU.S.LifeScienceTools&DiagnosticsNEUTRALU
11、nchangedU.S.LifeScienceTools&DiagnosticsJackMeehanCFA12125263909jack.meehan@BCIUSMitchellPetersen12125263367mitchell.petersen@BCIUSrewWald12125269436rew.wald@BCIUSBarclays|U.S.LifeScienceTools&Diagnostics7June20183Bruker
12、BrukerkickedoffASMSdirectingamajityofitsfocusononeproductintroductionaswellasthe“relaunch”ofanotherimpactfulinstrument.TherewasalotofinterestaroundthelaunchofthescimaXMRMSwhichthecompanybelieveswillmakeasignificantimpact
13、inproteomicsphenomics.ThepreviouslyintroducedtimsTOFProwasalsoanareaoffocusfBruker.?scimaXMRMS:CEOFrankLaukienbelievesthatMRMShas“averybrightfuture”thatthescimaXintroductionis“revolutionary.”Specificallyheexpectsthelaunc
14、htobeimpactfulinmovingproteomicsphenomicstotheclinicalsetting.LaukiendescribedthescimaXasthe“mostpowerfulmassspeceverbuilt”withmassresolutiongreaterthan20million.Thehighlevelofresolutionenablestheuseofisotopicfinestructu
15、re(IFS)analysis.AdditionallytheinstrumentfeaturesimprovedeaseofuseenablingnativeMSvirtually“outofthebox.”Thehighthroughputinstrumentcantestupto200samplesperday.AsanexampleoftherobustnessaresearcherinattheImperialCollegeL
16、ondonperfmedover1100testswithoutstopping.ImptantlythescimaXutilizesBruker’snovelMaxwellmagtechnologywhichcoolstheinstrumentviausingcompressedhelium.Thesystemrequiresmaintenancejustonceeverytwoyears.Thisisasubstantialimpr
17、ovementoverBruker’sotherMRMSinstrumentsinwhichliquefiedheliummustbereplacedeveryfewweeks.Theproductispricedat$1.25millioncustomersareexpectedtobesplitfmthebiopharmaacademicendmarkets.Brukersellsroughly15MRMSinstrumentsan
18、nuallythoughthecompanyexpectsthisnumbertoincreasemovingfward.?timsTOFPro:ThecompanyalsodiscussedthetimsTOFProwhichwaslaunchedatHUPO2017inDublin.ThecompanybelievesthetimsTOFProisa“gamechanger”inproteomicsfeaturingunpreced
19、entedrobustnessincreasesensitivityspeed.AccdingtoanumberofresearchersthesensitivityofthetimsTOFishigherthananyotherinstrumentsinthefieldofproteomics.OneresearcherMatheusMannrecentlypublishedapaperonthetimsTOFnotingthatit
20、featuresa50xgaininsensitivity.Thisisespeciallyimptantfbiopharmacustomerswhichrequirehighsensitivityaquickpaceoftestingatareproduciblelevel.Thecompanyhasalreadyseenmuchinterestfrompharmacompaniesthoughearlycustomershavema
21、inlybeenfromtheacademicsetting.ThetimsTOFProispricedatroughly$700Kthecompanyhasplaced10instrumentssofar.ThermoFisherIainMylchreestVPofR&DchromatographymassspectrometryatThermoFisherhighlightedthreenewmassspectrometryoffe
22、rings.Eachplatfmisgearedtowardadifferentmarketincludingstructuralbiologymetabolomicsappliedtesting.Thecompanyalsonotedthatithasbeenmakingverysignificantinvestmentsinsoftware.ThoughsomecustomersarestillrelianttosharedataT
23、hermoFishercontinuestoreceiveadditionalrequestsfcloudconnectivity.IntermsofremotemonitingfeedbackhasbeenverypositivewithcustomersgreatlypreferringinstantaneouscommunicationwithThermoFisherwhenasystemrequiresservicing.?QE
24、xactiveUHMRQuadrupoleMassSpec:Thecompanyconsiderstheinstrumenttobe“novel”withthepotentialtoopennewopptunitiesinstructuralbiology.WhilethebitraphashisticallyanalyzedsmallermoleculesinstructuralbiologytheQExactiveUHMRanaly
25、zeslargermolecules.Asaresulttheinstrument’smassrangewasextendedto80K.Anotherfeatureoftheinstrumentistheabilitytoseparatemoleculesonitsown.ImptantlyThermoFisherbelievesthattheQExactiveUHMRis“verycomplimentary”tothecompany
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 美國生命科學(xué)與診斷jack工具包——第4卷第45期2018年q3盈利最新要點(diǎn)
- 美國生命科學(xué)與診斷jack工具包——第4卷第44期關(guān)于市場價值評估的思考
- 巴克萊-美股-醫(yī)療保健行業(yè)-2018年q4美國生命科學(xué)與診斷10-k預(yù)覽產(chǎn)業(yè)要點(diǎn)與模型更新-2019.4.2-145頁
- 醫(yī)療保健行業(yè)醫(yī)藥行業(yè)2018年年報業(yè)績前瞻
- 美國生命科學(xué)與診斷2018年10月巴克萊工具產(chǎn)業(yè)追 蹤
- 歐洲-醫(yī)療保健行業(yè)-助聽器尋找下一個風(fēng)口
- 生命科學(xué)與健康第章遺傳講稿
- 醫(yī)療保健行業(yè)推進(jìn)藥店分級分類管理,加速行業(yè)整合及轉(zhuǎn)型升級
- absoluteidq p180 kit biocrates life sciences ag(absoluteidq p180工具包biocrates生命科學(xué)ag))
- 醫(yī)療保健行業(yè)兩票制調(diào)整接近尾聲,期待現(xiàn)金流改善
- 醫(yī)療保健行業(yè)創(chuàng)新藥系列研究五定價,進(jìn)口創(chuàng)新藥定價真的更低了
- 衛(wèi)生院健康保健工具包培訓(xùn)
- java工具包
- 生命科學(xué)與技術(shù)學(xué)部第4期黨的基本知識學(xué)習(xí)班學(xué)習(xí)計劃
- 保健行業(yè)資料
- 醫(yī)療保健行業(yè)醫(yī)藥板塊估值已經(jīng)處于歷史低位,目前是較好配置時點(diǎn)
- 醫(yī)療保健
- 醫(yī)療保健行業(yè)新版基藥目錄推出,基藥擴(kuò)容有望加大醫(yī)保覆蓋面
- 醫(yī)療保健行業(yè)深度報告三點(diǎn)邏輯,帶動特色原料藥行業(yè)開啟長期景氣周期
- 招聘技術(shù)工具包
評論
0/150
提交評論